Order Article Reprints

Huang W-C, Yadav VK, Cheng W-H, Wang C-H, Hsieh M-S, Huang T-Y, Lin S-F, Yeh C-T, Kuo K-T. The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells. Cancers. 2021; 13(23):6005. https://doi.org/10.3390/cancers13236005

Huang, Wen-Chien, Vijesh Kumar Yadav, Wei-Hong Cheng, Chun-Hua Wang, Ming-Shou Hsieh, Ting-Yi Huang, Shiou-Fu Lin, Chi-Tai Yeh, and Kuang-Tai Kuo. 2021. "The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells" Cancers 13, no. 23: 6005. https://doi.org/10.3390/cancers13236005

Huang, W.-C., Yadav, V. K., Cheng, W.-H., Wang, C.-H., Hsieh, M.-S., Huang, T.-Y., Lin, S.-F., Yeh, C.-T., & Kuo, K.-T. (2021). The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells. Cancers, 13(23), 6005. https://doi.org/10.3390/cancers13236005